Who is sponsoring NCT04818294?

NCT04818294 is sponsored by Elosan AG.

What drugs are being tested in NCT04818294?

Interventions in NCT04818294: Pain treatment by electrostatic charge to the whole body.

What condition does NCT04818294 study?

NCT04818294 studies Chronic Pain.

Is NCT04818294 still recruiting?

NCT04818294 is currently completed. Last updated 26 January 2023.

Last reviewed 2023-01-26 · How we verify

NCT04818294

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial to Monitor the Efficacy of the Elosan Treatment by Applying Electrostatic

Completed Last updated 26 January 2023

What this trial tests

trial testing Pain treatment by electrostatic charge to the whole body in Chronic Pain in 192 participants. Completed in 15 June 2022.

Timeline

16 March 2021

Primary endpoint
15 May 2022

15 June 2022

Quick facts

Lead sponsor	Elosan AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	192
Start date	16 March 2021
Primary completion	15 May 2022
Estimated completion	15 June 2022
Sites	8 locations across Switzerland

Drugs / interventions tested

Pain treatment by electrostatic charge to the whole body

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

Elosan AG

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Treatment Cabin 'Elosan cabin' is a closed, electrically insulated cabin for the short-term application of a high electrostatic voltage to the body of patients with chronic pain. Patients assigned will have 8 sessions in the treatment cabin, with an interval of 6 days between sessions. The existing therapies and painkillers will be continued at the discretion of the doctor.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Whole-Body Electrostatic Pain Treatment in Adults with Chronic Pain: A Prospective Multicentric Observational Clinical Trial.
Steinhauser S, Ganter MT, Stadelmann V, Hofer CK, et al · · 2024 · cited 1× · PMID 38015366 · DOI 10.1007/s40122-023-00560-8

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Elosan AG trials

Trials by the same sponsor.

NCT03823729 — Elosan Efficacy Study (EES) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04818294 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Elosan AG
Last refreshed: 26 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04818294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing